Jelena Martinov Nestorov

Jelena Martinov Nestorov

Auto-generated profile, based on publicly available information

Jelena Martinov Nestorov

University Clinical Centre of Serbia, Clinic for Gastroenterology and Hepatology, School of Medicine, University of Belgrade, Belgrade, Serbia

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2025 in Journal of the Serbian Chemical Society
Verified
Journal Article
Open access
PDF file
JNJelena Martinov Nestorov
Jelena Martinov Nestorov
GJGoran V. Janjić
Goran V. Janjić
MBMarija Petkovic Benazzouz
Marija Petkovic Benazzouz
Pectin is the focus of scientific interest due to both its physicochemical and biochemical properties, as well as its non-toxic nature. Methylation of pectin is a natural process that exists as part of the cell wall defence system against various pathogens. In this study the docking analysis was conducted to predict if methylation o affects the anticancer and antimicrobial properties of pectin and what extent. Four pectin derivatives with varying degrees of methylation and two sets of biomolecules were used. The first set included enzymes responsible for anticancer activity (HMGR, the AGE receptors, tumour protein p53 and oncogenic phosphatase SHP2), while the second set included those for antimicrobial activity (Salmonella Typhi TtsA, Pseudomonas aeruginosa Earp, Streptococcus mutans MetE and Staphylococcus aureus Cas9). The results indicated that the degree of methylation does not play a decisive role in the mentioned activities. because all bind to the same sites with similar binding energies. Additionally, it was shown that pectin derivatives have a higher binding affinity towards DNA than towards enzymes. Only the fully methylated derivative exhibited different behaviour, binding to a different binding site in the case of Streptococcus mutans MetE.

1 January 2023 in Medicinska istrazivanja
Verified
Journal Article
Open access
PDF file
TGTijana Glisic
Tijana Glisic
DPDusan Dj Popovic
Dusan Dj Popovic
MLMilica Stojkovic Lalosevic
Milica Stojkovic Lalosevic
JMJelena Martinov
Jelena Martinov
MSMarija Stojanovic
Marija Stojanovic
VJVladimir Jurisic
Vladimir Jurisic
Introduction/aim: Nitric oxide (NO) is a key mediator which, paradoxically, regulates sinusoidal (intrahepatic) and systemic/splanchnic circulation. The main goal of this study was to measure NO and compare serum values of NO with flow data in visceral blood vessels of the liver, spleen, kidney and intestine in patients with cirrhosis. Material and methods: This prospective study included 80 patients with cirrhosis of the liver. Doppler ultrasonography was used to assess flow velocity and resistive index (RI) in the hepatic (HA), right (RRA), and left renal (LRA), splenic (SA) and superior mesenteric artery (SMA). NO concentration was determined using the DetectX® Nitric Oxide colorimetric detection kit. Results: We found a statistically significant difference in the mean NO value in the group of patients without ascites compared to the ascites group, as well as in the group of patients with A stage in relation to C stage of cirrhosis (p <0.05). There is statistically significant negative correlation between NO and diameter, and maximal and minimal velocity in LRA. There is significant positive correlation between NO and minimal velocity in SMA. Conclusions: In this study, we found that patients with cirrhosis of the liver were exposed to significantly higher RI LRA, RRA, SA and HA. In patients with cirrhosis complicated by ascites and in those with end stage liver disease, the NO level was significantly higher. The concentration of NO had an effect on the diameter and flow rate in the LRA and flow rate in SMA.

1 January 2026 in Medicinska istrazivanja
Verified
Journal Article
Open access
PDF file
DPDusan Dj Popovic
Dusan Dj Popovic
MMMarija Marjanovic-Haljilji
Marija Marjanovic-Haljilji
DMDragana Mijac
Dragana Mijac
NMNestorov Jelena Martinov
Nestorov Jelena Martinov
JTJasna Trbojevic-Stanković
Jasna Trbojevic-Stanković
BFBranka Filipovic
Branka Filipovic
Portal hypertension is defined as an increase in the hepatic venous pressure gradient, most commonly resulting from liver cirrhosis and leading to the development of portosystemic collaterals, particularly esophageal varices. At the time of cirrhosis diagnosis, approximately 50% of patients have esophageal varices, and variceal bleeding represents one of the most severe and life-threatening complications in gastroenterology. Esophagogastroduodenoscopy is the cornerstone for both diagnosis and treatment of acute variceal bleeding. Therapeutic options include endoscopic hemostasis, pharmacological therapy, balloon tamponade, interventional radiology procedures, and surgical interventions. Endoscopic band ligation is the preferred first-line endoscopic treatment, while sclerotherapy, involving intravariceal or paravariceal injection of sclerosant agents, is now used less frequently. Pharmacological management includes splanchnic vasoconstrictors such as octreotide, terlipressin, vapreotide, and somatostatin analogues, along with supportive measures including fluid resuscitation, blood product transfusion, and correction of coagulopathy. Prophylactic antibiotic therapy, most commonly with fluoroquinolones or cephalosporins, is mandatory in cirrhotic patients with variceal bleeding. Balloon tamponade using devices such as Sengstaken-Blakemore, Minnesota, or Linton-Nachlas tubes serves as a temporary rescue therapy. In cases refractory to standard treatment, transjugular intrahepatic portosystemic shunt (TIPS) or surgical management may be considered in carefully selected patients. Management of variceal bleeding requires intensive care and a multidisciplinary approach.